bioAffinity Technologies
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has bioAffinity Technologies's balance sheet done over the years? Its assets were worth $8,221,552 last year, which is less than in the previous period. 41% of bioAffinity Technologies’s total assets is currently financed by debt. Its liabilities reached the amount of $3,366,297, which means an increase by 196% compared compared to last year.

Debt to Assets

bioAffinity Technologies, Inc. (NASDAQ:BIAF): Debt to assets
2019 658810 4.69M 712.55%
2020 145605 15.21M 10451.89%
2021 1453308 17.24M 1186.54%
2022 12182125 1.13M 9.35%
2023 8221552 3.36M 40.94%

BIAF Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
2.82M11.41M1.36M83.10K578.48K
Short term investments
00000
Net receivables
811.67K10.48K1.53K1.53K1.53K
Inventory
18.48K5.54K71.84K28.35K0
Other current assets
321.01K119.77K4.21K5.66K37.49K
Total current assets
3.97M11.96M1.43M118.65K617.50K
Non-current assets:
Property, Plant and Equipment
1.99M214.43K4.63K9.45K28.80K
Goodwill
1.40M0000
Intangible assets
833.47K0000
Long term investments
00000
Other non-current assets
16.06K6K10.44K17.5K12.5K
Total non-current assets
4.24M220.43K15.07K26.95K41.30K
Total assets
8.22M12.18M1.45M145.60K658.81K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
33.05K0000
Short term debt
920.34K251.74K11.20M9.95M4.01M
Total current liabilities
2.24M1.13M13.03M11.12M4.69M
Non-current liabilities:
Long term debt
1.11M0160.18K53.46K0
Deferred tax
00000
Other non-current liabilities
0596.78K4.04M4.04M0
Total non-current liabilities
1.11M596.78K4.20M4.09M0
Total liabilities
3.36M1.13M17.24M15.21M4.69M
Data sourceData source